Loading
Palitra Bio
Palitra Bio tests candidate treatments directly against a patient's own tumour cells, with a PhD data team and an MD tumour board turning the results into a personalised treatment plan.
Overview
Palitra Bio offers what it calls maximalist functional testing: rational therapeutic options are tested against the patient's own tumour cells, matched to malignancy, stage and goals of care, and synthesised by a data team and a medical tumour board into guidance for the treating clinicians. Its chief executive brings fifteen years at the intersection of cancer biology and translational research. It is an Even One Ventures portfolio company.
Headquarters
United States (head office not published), US
Funding
All startupsStartup
Investors
Type
Stage
Startup
Website
Connected
3Similar pages
- CompanyKernis Health
Shares Even One Ventures, Functional (ex vivo) drug testing and the tags startup, evenone-portfolio, oncology.
- CompanyValius Sciences
Shares Even One Ventures, Functional (ex vivo) drug testing and the tags startup, evenone-portfolio, oncology.
- CompanyRanata Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyRelit Biosciences
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyEcho Immune
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyMinuteman Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyInvocata
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyYuga Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
technologies
companies
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
evenone.ventures · 1
palitra.bio · 1
A source that has moved or gone is reported by the weekly link check. /audit/